|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
674,040,000 |
Market
Cap: |
16.37(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$17.15 - $26.07 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
27,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
27,872 |
27,872 |
60,449 |
163,424 |
Total Sell Value |
$687,456 |
$687,456 |
$1,380,595 |
$4,309,849 |
Total People Sold |
3 |
3 |
4 |
5 |
Total Sell Transactions |
4 |
4 |
6 |
15 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gourdier Benoit |
EVP, Biopharma Production |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
25,667 |
42,453 |
|
- |
|
Stubblefield Michael |
President & CEO |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
107,802 |
1,219,553 |
|
- |
|
Bramwell James |
EVP Sales, Customer Excellence |
|
2024-02-23 |
4 |
D |
$24.35 |
$13,855 |
D/D |
(569) |
89,279 |
|
- |
|
Eck Steven W |
SVP & Chief Accounting Officer |
|
2024-02-23 |
4 |
D |
$24.35 |
$10,276 |
D/D |
(422) |
27,330 |
|
- |
|
Stubblefield Michael |
President & CEO |
|
2024-02-23 |
4 |
D |
$24.35 |
$180,726 |
D/D |
(7,422) |
1,129,031 |
|
- |
|
Hankamer Brittany |
EVP, Chief HR Officer |
|
2024-02-23 |
4 |
D |
$24.35 |
$10,251 |
D/D |
(421) |
24,479 |
|
- |
|
Couturier Christophe |
EVP, AMEA |
|
2024-02-23 |
4 |
D |
$24.35 |
$10,130 |
D/D |
(416) |
88,838 |
|
- |
|
Bramwell James |
EVP Sales, Customer Excellence |
|
2024-02-22 |
4 |
D |
$24.59 |
$69,885 |
D/D |
(2,842) |
89,848 |
|
- |
|
Bramwell James |
EVP Sales, Customer Excellence |
|
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
7,432 |
92,690 |
|
- |
|
Stubblefield Michael |
President & CEO |
|
2024-02-22 |
4 |
D |
$24.59 |
$1,012,542 |
D/D |
(41,177) |
1,136,453 |
|
- |
|
Stubblefield Michael |
President & CEO |
|
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
99,075 |
1,177,630 |
|
- |
|
Couturier Christophe |
EVP, AMEA |
|
2024-02-22 |
4 |
D |
$24.59 |
$63,295 |
D/D |
(2,574) |
89,254 |
|
- |
|
Couturier Christophe |
EVP, AMEA |
|
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,290 |
91,828 |
|
- |
|
Hankamer Brittany |
EVP, Chief HR Officer |
|
2024-02-20 |
4 |
D |
$24.05 |
$6,950 |
D/D |
(289) |
24,900 |
|
- |
|
Stubblefield Michael |
President & CEO |
|
2024-02-20 |
4 |
D |
$24.05 |
$233,550 |
D/D |
(9,711) |
1,078,555 |
|
- |
|
Couturier Christophe |
EVP, AMEA |
|
2024-02-20 |
4 |
D |
$24.05 |
$33,478 |
D/D |
(1,392) |
82,538 |
|
- |
|
Bramwell James |
EVP Sales, Customer Excellence |
|
2024-02-20 |
4 |
D |
$24.05 |
$29,245 |
D/D |
(1,216) |
85,258 |
|
- |
|
Eck Steven W |
SVP & Chief Accounting Officer |
|
2024-02-20 |
4 |
D |
$24.05 |
$10,462 |
D/D |
(435) |
27,752 |
|
- |
|
Lewis Sheri |
EVP, Global Ops & Supply Chain |
|
2023-12-31 |
4 |
D |
$22.83 |
$104,013 |
D/D |
(4,556) |
70,692 |
|
- |
|
Gourdier Benoit |
EVP, Biopharma Production |
|
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,786 |
16,786 |
|
- |
|
Eck Steven W |
SVP & Chief Accounting Officer |
|
2023-09-07 |
4 |
S |
$20.64 |
$156,389 |
D/D |
(7,577) |
28,187 |
|
-3% |
|
Hankamer Brittany |
EVP, Chief HR Officer |
|
2023-09-05 |
4 |
D |
$21.70 |
$6,705 |
D/D |
(309) |
25,189 |
|
- |
|
Vanderhaegen Frederic |
EVP, Americas and Europe |
|
2023-08-25 |
4 |
S |
$21.47 |
$536,750 |
D/D |
(25,000) |
160,735 |
|
-1% |
|
Hankamer Brittany |
EVP, Chief HR OfficerOfficer |
|
2023-08-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,498 |
|
5% |
|
Eck Steven W |
SVP & Chief Accounting Officer |
|
2023-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,584 |
35,764 |
|
- |
|
534 Records found
|
|
Page 2 of 22 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|